(Press-News.org) TUCSON, Ariz, May 20, 2024 – Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced its inaugural biologics-focused Request for Proposals (RFP) in its Bridging Research and Innovation in Drug Development Grants program (BioBRIDGe). BioBRIDGe awards are designed to help academic researchers traverse the drug development valley of death by providing funding and defining optimal strategies for advancing new, cutting-edge protein-based therapeutics (PBT) from the lab to patients.
For this funding cycle, TRxA is accepting proposals for PBT projects focused on rare and orphan disease, neurodegeneration, and pediatric indications. Eligible platforms include:
Peptides or proteins
Regular, bivalent or trivalent antibodies
Antibody-drug conjugates
Maaike Everts, Ph.D., Executive Director of C-Path’s TRxA, expressed her enthusiasm for the program’s expansion into biologics, stating, “The impactful progress in our currently funded projects in small molecules serves as a testament to the power of collaboration in drug discovery and development. We look forward to expanding into biologics, with protein-based therapeutics representing exciting platforms that exemplify the next generation of life changing medicines.”
As a drug accelerator within C-Path, TRxA provides the following for principal investigators who are selected to receive a BioBRIDGe award:
Tactical and strategic drug discovery and development expertise, including regulatory science considerations.
Resources and hands-on guidance, working closely with academic researchers to develop comprehensive data packages for potential drug candidates, a key to garnering interest from biotechnology and pharmaceutical companies to invest in clinical trials.
Engagement of contract research organizations (CRO) to perform critical discovery phase experiments and/or validate academic studies.
Pre-proposal applications must be submitted online here and will be accepted through June 27, 2024, at midnight in the time zone you are located. More information about this funding opportunity is available in TRxA’s BioBRIDGe Guidance Document for Applicants.
To learn more, visit c-path.org/programs/trxa or email TRxA at trxa@c-path.org.
About Critical Path Institute
Critical Path Institute (C-Path) is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is located in Tucson, Arizona and C-Path’s Europe subsidiary is headquartered in Amsterdam, Netherlands. For more information, visit c-path.org.
About Translational Therapeutics Accelerator (TRxA)
Critical Path Institute’s Translational Therapeutics Accelerator (TRxA) is a global drug accelerator focused on supporting academic scientists in advancing novel therapeutics from university-based labs to drug development pipelines of pharmaceutical companies and, ultimately, the clinic. As a nonprofit neutral convener of patient groups, academia, pharmaceutical companies and regulatory agencies, C-Path brings a breadth of scientific and drug development planning not available in other accelerator programs. TRxA is uniquely situated to leverage the expertise available through C-Path’s >20 disease-based consortia, as well as regulatory expertise and project management, to empower academic investigators to succeed in bringing safe and effective treatments to patients. For more information, visit c-path.org/trxa or email trxa@c-path.org.
Contacts:
Roxan Triolo Olivas
C-Path
520.954.1634
rolivas@c-path.org
Kissy Black
C-Path
615.310.1894
kblack@c-path.org
END
C-Path’s TRxA announces its first biologics-focused RFP for academic investigators
New funding opportunity!
2024-05-20
ELSE PRESS RELEASES FROM THIS DATE:
Enhancing superconductivity of graphene-calcium superconductors
2024-05-20
Superconductors are materials that can conduct electricity with zero resistance when they are cooled below a certain critical temperature. They have applications in several fields, including magnetic resonance imaging, particle accelerators, electric power, and quantum computing. However, their widespread use is limited by the need for extremely low temperatures. Graphene-based materials are promising for superconductors due to their unique properties such as optical transparency, mechanical strength, and flexibility. Graphene is a single layer of carbon (C) atoms arranged in a two-dimensional honeycomb structure. Among these materials, ...
Federal Trade Commission actions on prescription drugs, 2000-2022
2024-05-20
About The Study: The Federal Trade Commission (FTC) brought about one enforcement action and three merger actions per year against pharmaceutical manufacturers from 2000-2022, pursuing a small fraction of the estimated misconduct and consolidation in the pharmaceutical marketplace. Although the FTC faces substantial legal and practical limitations, important tools remain untested, including a rule defining “unfair methods of competition,” that may allow it to more effectively prevent repetitive patterns of anticompetitive behavior.
Corresponding Author: To contact the corresponding author, Aaron S. Kesselheim, ...
Fluoride exposure during pregnancy linked to increased risk of childhood neurobehavioral problems, study finds
2024-05-20
Nearly three-quarters of the United States population receives drinking water that contains fluoride, a practice that began in 1945 to help prevent tooth decay. But recent studies suggest that fluoride exposure can cause harm to a fetus if consumed during pregnancy, a critical period for brain development.
A new study, led by researchers at the Keck School of Medicine of USC and funded in part by the National Institutes of Health, analyzed more than 220 mother-child pairs, collecting data on fluoride levels during pregnancy and child behavior at age three. The researchers found that a 0.68 milligram per ...
The Ukraine war caused migrating eagles to deviate from their usual flight plan
2024-05-20
When migrating through Ukraine in 2022, Greater Spotted Eagles were exposed to multiple conflict events that altered their migratory course, according to a study reported on May 20 in the journal Current Biology. Greater Spotted Eagles are large raptors that are classified as a vulnerable species by the International Union for Conservation of Nature (IUCN).
“Armed conflicts can have wide-ranging impacts on the environment, including changes in animal behavior,” says Charlie Russell (@CJG_Russell) of the University of East Anglia, UK. “Our ...
Endangered migrating eagles impacted by Ukraine war
2024-05-20
A new study reveals for the first time the impact of ongoing conflicts on the migration of an endangered bird species.
Researchers from the University of East Anglia (UEA), the British Trust for Ornithology (BTO) and the Estonian University of Life Sciences compared the movement and migration of the Greater Spotted Eagle through Ukraine, before and shortly after it was invaded by Russia in February 2022.
They were already studying the species when the war started, with the dangers faced by migratory birds usually related to disruptive weather or drought, changes in land use affecting traditional stopping-off ...
Study explores association between fluoride exposure in pregnancy and neurobehavioral issues in young children
2024-05-20
Higher fluoride levels in pregnant women are linked to increased odds of their children exhibiting neurobehavioral problems at age 3, according to a new study led by a University of Florida College of Public Health and Health Professions researcher.
The findings, based on an analysis involving 229 mother-child pairs living in a U.S. community with typical fluoride exposure levels for pregnant women in fluoridated regions in North America, appear May 20 in the journal JAMA Network Open. It is believed to be the first U.S.-based study to examine associations of prenatal fluoride exposure ...
Using magnetic resonance spectroscopy to design safer, higher-performance lithium batteries
2024-05-20
Columbia Engineers use nuclear magnetic resonance spectroscopy to examine lithium metal batteries through a new lens -- their findings may help them design new electrolytes and anode surfaces for high-performance batteries
New York, NY—May 20, 2024—A Columbia Engineering team has published a paper in the journal Joule today that details how nuclear magnetic resonance spectroscopy techniques can be leveraged to design the anode surface in lithium metal batteries. The researchers also present new data and interpretations for how this method can be used to gain unique insight into the structure of these surfaces to share with the field.
“We ...
Should your exercise goals be in minutes or steps? Study suggests they are equally beneficial
2024-05-20
In the age of smartwatches, monitoring step counts has never been easier, but current physical activity guidelines do not explicitly recommend specific step counts for health. A new study from researchers at Brigham and Women’s Hospital, a founding member of Mass General Brigham, suggests that both step and time-based exercise targets are equivalently associated with lower risks of early death and cardiovascular disease. Thus, whether one chooses a time or step goal may not be as important as choosing a goal aligned with personal preferences. Results are published in JAMA Internal Medicine.
Physical activity reduces the risk of acquiring chronic illness and ...
Racial and ethnic inequities in cancer care continuity during the COVID-19 pandemic among those with SARS-CoV-2
2024-05-20
About The Study: In this cross-sectional study of patients with cancer and SARS-CoV-2, racial and ethnic inequities existed in treatment delays and discontinuations throughout the pandemic; however, the disproportionate burden among racially and ethnically minoritized patients with cancer varied across SARS-CoV-2 waves. These inequities may lead to downstream adverse impacts on cancer mortality among minoritized adults in the United States.
Corresponding Author: To contact the corresponding author, Jessica Y. Islam, Ph.D., M.P.H., email jessica.islam@moffitt.org.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.12050)
Editor’s ...
Effect of sleep restriction on adolescent cognition by adiposity
2024-05-20
About The Study: Adolescents with overweight or obesity may be more vulnerable to negative cognitive effects following sleep restriction. Improved sleep hygiene and duration in this group may positively impact their cognitive health.
Corresponding Author: To contact the corresponding author, Aaron D. Fobian, Ph.D., email afobian@uabmc.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaneurol.2024.1332)
Editor’s ...
LAST 30 PRESS RELEASES:
A new discovery about the source of the vast energy in cosmic rays
Cancer ‘fingerprint’ can improve early detection
Rethinking the brain pacemaker: How better materials can improve signals
Allostatic load, educational attainment, and risk of cancer mortality among us men
Flaw in computer memory leads to global security fixes
Race, ethnicity, and sleep in us children
Geriatric surgery verification program can improve outcomes for older cancer patients in community hospitals
Pew funds 8 teams to conduct collaborative biomedical research
Finding innovative ways to address kidney cancer leads to DoD grant
Americans are uninformed about and undervaccinated for HPV
KTU scientists developed a nanolaser: silver nanocubes enable light generation
Insilico Medicine nominates orally available pre-clinical candidate targeting NLRP3 to treat inflammation and central nervous system diseases
PLOS receives $3.3 million grant to support Open Access publishing & business model transformation
HBx facilitates drug resistance in hepatocellular carcinoma via CD133-regulated self-renewal of liver cancer stem cells
ASN congratulates members for their role in the development of the Scientific Report of the 2025 Dietary Guidelines Advisory Committee
Late-stage breast cancer diagnosis on the rise in US
Brain volume changes seen in opioid users
Ultra-processed foods may drive colorectal cancer risk, USF-TGH study finds
Two Case Western Reserve University faculty members honored as Fellows of the National Academy of Inventors
How this cancer drug could make radiation a slam dunk therapy
National TRAP Program funds large-scale cleanup of discarded fishing gear
Using ‘biological age’ to predict early colorectal cancer risk
National Academy of Inventors announces Class of 2024 Fellows
SwRI showcases capabilities, evaluates novel fire-safety method with customized test
Caring for the emotional and spiritual needs of family members of ICU patients
Navigating crises: The financial adaptations of NGOs during the COVID-19 pandemic
Early life exposure to toxic chemicals may cause behavioral, psychological problems
AI predicts Earth’s peak warming
Risk of coronary artery disease in patients with liver cirrhosis: A systematic review and meta-analysis
Wild birds’ gut microbiome linked with its ornamentation and body condition
[Press-News.org] C-Path’s TRxA announces its first biologics-focused RFP for academic investigatorsNew funding opportunity!